XML 66 R56.htm IDEA: XBRL DOCUMENT v3.7.0.1
Equity Incentive Program - Stock Options and SSARs (Details) - USD ($)
$ / shares in Units, $ in Millions
6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Document Fiscal Year Focus 2017  
SSARs    
Number of Shares [Roll Forward]    
Beginning balance 898,718  
Granted 0  
Exercised 31,665  
Forfeited 0  
Expired (16,537)  
Ending balance 850,516  
Exercised 850,516  
Weighted Average Grant Date Fair Value    
Beginning balance $ 21.25  
Granted 0.00  
Exercised 12.33  
Forfeited 0.00  
Expired 23.20  
Ending balance 21.54  
Exercisable $ 21.54  
SARS and Options, Additional Disclosures    
SSARs, aggregate intrinsic value, outstanding $ 0.3  
SSARs, aggregate intrinsic value, exercisable $ 0.3  
SSARs, weighted average remaining contractual terms, outstanding 4 years 6 months  
SSARs, weighted average remaining contractual term, exercisable 4 years 6 months  
Stock Options    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]    
Dividend yield 0.00% 0.00%
Expected life (years) 4 years 6 months 4 years 6 months
Stock Options, Number of Shares    
Beginning balance 4,684,117  
Granted 779,561  
Exercised 218,389  
Forfeited (223,893)  
Expired (54,982)  
Ending balance 4,966,414  
Exercisable 2,213,679  
Stock Options, Weighted Average Exercise Price    
Beginning balance $ 18.03  
Granted 19.21  
Exercised 14.49  
Forfeited 15.35  
Expired 26.77  
Ending balance 18.38  
Exercisable $ 20.53  
SARS and Options, Additional Disclosures    
Options, aggregate intrinsic value, outstanding $ 9.6  
Options, aggregate intrinsic value, exercisable $ 2.9  
Options, weighted average remaining contractual term, outstanding 5 years 2 months  
Options, weighted average remaining contractual term, exercisable 4 years 7 months  
Minimum | Stock Options    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]    
Risk-free interest rate 0.00% 0.00%
Volatility 38.10% 37.00%
Fair value at date of grant $ 6.07 $ 3.76
Maximum | Stock Options    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]    
Risk-free interest rate 0.00% 0.00%
Volatility 0.00% 0.00%
Fair value at date of grant $ 6.73 $ 4.27